| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.006 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0023 | 1 |